NO20000576L - Blanding og fremgangsmåte for regulering av celleproliferasjon og celledød - Google Patents

Blanding og fremgangsmåte for regulering av celleproliferasjon og celledød

Info

Publication number
NO20000576L
NO20000576L NO20000576A NO20000576A NO20000576L NO 20000576 L NO20000576 L NO 20000576L NO 20000576 A NO20000576 A NO 20000576A NO 20000576 A NO20000576 A NO 20000576A NO 20000576 L NO20000576 L NO 20000576L
Authority
NO
Norway
Prior art keywords
composition
cell
mixture
controlling
dna
Prior art date
Application number
NO20000576A
Other languages
English (en)
Other versions
NO20000576D0 (no
NO322450B1 (no
Inventor
Nigel C Phillips
Mario C Filion
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Inc filed Critical Bioniche Inc
Publication of NO20000576D0 publication Critical patent/NO20000576D0/no
Publication of NO20000576L publication Critical patent/NO20000576L/no
Publication of NO322450B1 publication Critical patent/NO322450B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20000576A 1997-08-05 2000-02-04 Blanding for regulering av celleproliferasjon og celledod samt anvendelse derav NO322450B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5477797P 1997-08-05 1997-08-05
US7506798P 1998-02-18 1998-02-18
US7511198P 1998-02-18 1998-02-18
US8631798P 1998-05-21 1998-05-21
PCT/CA1998/000744 WO1999007383A1 (en) 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death

Publications (3)

Publication Number Publication Date
NO20000576D0 NO20000576D0 (no) 2000-02-04
NO20000576L true NO20000576L (no) 2000-04-04
NO322450B1 NO322450B1 (no) 2006-10-09

Family

ID=27489673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000576A NO322450B1 (no) 1997-08-05 2000-02-04 Blanding for regulering av celleproliferasjon og celledod samt anvendelse derav

Country Status (17)

Country Link
US (2) US6326357B1 (no)
EP (1) EP1003525B1 (no)
JP (2) JP4335435B2 (no)
KR (1) KR100533576B1 (no)
AT (1) ATE227996T1 (no)
AU (1) AU736450B2 (no)
BR (1) BR9815602A (no)
CA (1) CA2299548C (no)
DE (1) DE69809561T2 (no)
DK (1) DK1003525T3 (no)
ES (1) ES2187047T3 (no)
HU (1) HU227921B1 (no)
IL (3) IL134371A0 (no)
NO (1) NO322450B1 (no)
NZ (1) NZ502674A (no)
PT (1) PT1003525E (no)
WO (1) WO1999007383A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003525B1 (en) 1997-08-05 2002-11-20 Bioniche Life Sciences Inc. Composition and method for regulating cell proliferation and cell death
WO1999042113A1 (en) * 1998-02-18 1999-08-26 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer
US6809081B1 (en) 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
DE69920506T2 (de) * 1998-12-04 2005-10-13 Bioniche Life Sciences Inc., London Chemotherapeutische zusammensetzung und verfahren
DK1135164T3 (da) * 1998-12-04 2004-12-20 Bioniche Life Sciences Inc Sammensætning til behandling af inflammation
US6794368B1 (en) * 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
ES2238996T3 (es) * 1999-04-01 2005-09-16 Bioniche Life Sciences Inc. Composicion y metodo para inducir apoptosis en celulas de cancer de prostata.
WO2001022979A1 (en) * 1999-09-29 2001-04-05 Bioniche Life Sciences Inc. Method to disrupt mitochondrial function
IL150196A0 (en) * 1999-12-13 2002-12-01 Bioniche Life Sciences Inc Therapeutically useful synthetic oligonucleotides
US7125858B2 (en) * 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US6673566B1 (en) 2002-01-10 2004-01-06 The United States Of America As Represented By The Secretary Of Agriculture Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes
JP2009544681A (ja) 2006-07-25 2009-12-17 リポクセン テクノロジーズ リミテッド エリスロポエチンの多糖誘導体
BR112013008727A2 (pt) * 2010-10-13 2016-06-28 Bioniche Urology Ip Inc composições de parede celular de ácido ribonucleico micobacteriano e métodos de fabricação e uso das mesmas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
FR2160326B1 (no) 1971-11-19 1975-02-07 Anvar
US4152423A (en) 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
CA1020460A (en) 1973-02-23 1977-11-08 Wellcome Foundation Limited (The) Isolation of immunostimulating glycopeptide from bacteria
US3976544A (en) 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4744984A (en) 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
CN1102855C (zh) 1993-01-29 2003-03-12 维特里制药有限公司 免疫治疗组合物
EP1003525B1 (en) 1997-08-05 2002-11-20 Bioniche Life Sciences Inc. Composition and method for regulating cell proliferation and cell death

Also Published As

Publication number Publication date
ATE227996T1 (de) 2002-12-15
NZ502674A (en) 2002-06-28
DE69809561T2 (de) 2003-09-25
AU8723698A (en) 1999-03-01
IL180924A0 (en) 2007-07-04
IL134371A0 (en) 2001-04-30
KR20010022643A (ko) 2001-03-26
US6326357B1 (en) 2001-12-04
IL134371A (en) 2007-07-24
US6329347B1 (en) 2001-12-11
PT1003525E (pt) 2003-03-31
HU227921B1 (hu) 2012-06-28
NO20000576D0 (no) 2000-02-04
CA2299548C (en) 2009-12-29
JP2001513504A (ja) 2001-09-04
HUP0003012A3 (en) 2004-03-29
HUP0003012A2 (hu) 2000-12-28
KR100533576B1 (ko) 2005-12-05
WO1999007383B1 (en) 1999-03-25
AU736450B2 (en) 2001-07-26
DE69809561D1 (de) 2003-01-02
WO1999007383A1 (en) 1999-02-18
ES2187047T3 (es) 2003-05-16
IL180924A (en) 2010-11-30
DK1003525T3 (da) 2003-03-24
CA2299548A1 (en) 1999-02-18
JP2008208140A (ja) 2008-09-11
BR9815602A (pt) 2001-12-11
JP4335435B2 (ja) 2009-09-30
EP1003525A1 (en) 2000-05-31
EP1003525B1 (en) 2002-11-20
NO322450B1 (no) 2006-10-09

Similar Documents

Publication Publication Date Title
IL180924A (en) Method for regulating cell proliferation and cell death
AU1926899A (en) Exploiting genomics in the search for new drugs
DK274688D0 (da) Aktivering ex vivo af effektor-celler til maalrettet celledrab
DE60031997D1 (de) Umkehrtransfektionsverfahren
AU3649397A (en) Precise efficacy assay methods for active agents including chemotherapeutic agents
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
MX244498B (es) Recombinacion especifica de la secuencia de adn en celulas eucarioticas.
NO973385L (no) Lymfotoksin-<alfa>/<beta>-komplekser og anti-lymfotoksin-beta-reseptor-antistoff som anti-svulstmidler
DE69012601D1 (de) Gentherapie durch stützgewebebezügliche Zellen.
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
DE3751280D1 (de) Enzyme als landwirtschaftliche chemische Hilfsmittel.
DE3875396D1 (de) Mikrotraegermaterial fuer die zellkultur.
IT7922818A0 (it) Procedimento per mantenere attiva la cultura di fermenti.
IT8721047A0 (it) Dispositivo per culture microbiologiche.
DE3673436D1 (de) Gene fuer biologisch aktive proteine.
DK323088A (da) Koeleanlaeg til braendeselsceller
ES2145051T3 (es) Procedimiento para el cultivo de un tipo de celula en el procedimiento de cocultivo con celulas de higado.
NL190728C (nl) Elektrodestructuur voor elektrochemische cellen.
JPS52156991A (en) Method for increasing activity of immobilized enzymes
ES8609470A1 (es) Procedimiento para la inmovilizacion de celulas de bacillus subtilis
JPS51133484A (en) Method for fixing of microbial cells
WO1997023607A3 (en) Presentation of antigen, introduced into cells by stimulation of macropinocytosis
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen
DK0887404T3 (da) Gen, som bibringer selektiv proliferationsaktivitet
SU1251528A1 (ru) Пленка - подложка для культивирования животных клеток

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BIONICHE UROLOGY IP INC, CA

RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees